Qiu S, Han H, Zhang H, Yang M, Wang H, Li K
Cancer Cell Int. 2025; 25(1):84.
PMID: 40057713
PMC: 11889767.
DOI: 10.1186/s12935-025-03715-z.
Komatsu S, Yano Y, Ishihara N, Kido M, Gon H, Fukushima K
Ann Gastroenterol Surg. 2025; 9(2):235-243.
PMID: 40046525
PMC: 11877347.
DOI: 10.1002/ags3.12893.
Lu L, Zhou X, Zheng J, Li D
J Hepatocell Carcinoma. 2025; 12:367-382.
PMID: 40008396
PMC: 11853879.
DOI: 10.2147/JHC.S500119.
Hashimoto H, Nojiri S, Takeda T, Urasaki W, Nishizaki Y, Nagahara A
Sci Rep. 2025; 15(1):6458.
PMID: 39987328
PMC: 11846871.
DOI: 10.1038/s41598-025-90734-5.
Hirata T, Endo S, Shirane N, Kawaguchi S, Ohno K
Cureus. 2025; 17(2):e79366.
PMID: 39980714
PMC: 11841750.
DOI: 10.7759/cureus.79366.
In vivo medical imaging for assessing geroprotective interventions in humans.
Svensson J, Schain M, Plaven-Sigray P
Geroscience. 2025; .
PMID: 39913033
DOI: 10.1007/s11357-025-01514-y.
Human immune system: Exploring diversity across individuals and populations.
Hoang Nguyen K, Le N, Nguyen P, Nguyen H, Hoang D, Huynh C
Heliyon. 2025; 11(2):e41836.
PMID: 39911431
PMC: 11795082.
DOI: 10.1016/j.heliyon.2025.e41836.
Artificial intelligence-assisted platform performs high detection ability of hepatocellular carcinoma in CT images: an external clinical validation study.
Shan R, Pei C, Fan Q, Liu J, Wang D, Yang S
BMC Cancer. 2025; 25(1):154.
PMID: 39871149
PMC: 11773783.
DOI: 10.1186/s12885-025-13529-x.
New insights into the structure domain and function of NLR family CARD domain containing 5.
Zhu H, Xiao C, Chen J, Guo B, Wang W, Tang Z
Cell Commun Signal. 2025; 23(1):42.
PMID: 39849460
PMC: 11755879.
DOI: 10.1186/s12964-024-02012-y.
Selenium in cancer management: exploring the therapeutic potential.
He L, Zhang L, Peng Y, He Z
Front Oncol. 2025; 14():1490740.
PMID: 39839762
PMC: 11746096.
DOI: 10.3389/fonc.2024.1490740.
NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials.
Khare T, Liu K, Chilambe L, Khare S
Int J Mol Sci. 2025; 26(1.
PMID: 39796162
PMC: 11720452.
DOI: 10.3390/ijms26010306.
Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development.
Todorovic N, Martinelli S, Nannini G, Weiskirchen R, Amedei A
Int J Mol Sci. 2025; 25(24.
PMID: 39769276
PMC: 11677376.
DOI: 10.3390/ijms252413510.
Cost-effectiveness of camrelizumab plus rivoceranib versus sorafenib as first-line treatment of unresectable hepatocellular carcinoma.
Zou H, Lai Y, Chen X, Ung C, Hu H
Therap Adv Gastroenterol. 2025; 18:17562848241310314.
PMID: 39758963
PMC: 11694292.
DOI: 10.1177/17562848241310314.
Identification of potential biomarkers for hepatocellular carcinoma based on machine learning and bioinformatics analysis.
Chen C, Peng R, Jin S, Tang Y, Liu H, Tu D
Discov Oncol. 2024; 15(1):808.
PMID: 39692931
PMC: 11655777.
DOI: 10.1007/s12672-024-01667-w.
Activatable Sulfur Dioxide Nanosonosensitizer Enables Precisely Controllable Sono-Gaseous Checkpoint Trimodal Therapy for Orthotopic Hepatocellular Carcinoma.
Liang J, Cheng G, Qiu L, Xue L, Xu H, Qiao X
Adv Sci (Weinh). 2024; 12(5):e2409442.
PMID: 39679828
PMC: 11791957.
DOI: 10.1002/advs.202409442.
Prognostic utility of gamma-glutamyl transpeptidase to platelet ratio in patients with solitary hepatitis B virus-related hepatocellular carcinoma after hepatectomy.
Yang C, Wei Z, Shen X, Jia Y, Wu Q, Wei Y
World J Gastrointest Oncol. 2024; 16(12):4579-4596.
PMID: 39678799
PMC: 11577363.
DOI: 10.4251/wjgo.v16.i12.4579.
Benefits and drawbacks of radiofrequency ablation percutaneous or minimally invasive surgery for treating hepatocellular carcinoma.
Hsieh C, Peng C, Chen C, Liu C, Teng C, Liu Y
World J Gastrointest Surg. 2024; 16(11):3400-3407.
PMID: 39649197
PMC: 11622093.
DOI: 10.4240/wjgs.v16.i11.3400.
Temporal trends of incidence, mortality, and survival of liver cancer during 2011-2020 in Fujian Province, Southeast China.
Xiang Z, Huang Y, Ma J, Lin Y, Wen Y, Zhou Y
Arch Public Health. 2024; 82(1):233.
PMID: 39633411
PMC: 11616380.
DOI: 10.1186/s13690-024-01462-7.
The prognostic utility of IGF-1 in hepatocellular carcinoma treated with stereotactic body radiotherapy.
Mohamed A, Sahin C, Berres M, Beetz O, von Websky M, Vogel T
Clin Transl Radiat Oncol. 2024; 50:100887.
PMID: 39624154
PMC: 11609351.
DOI: 10.1016/j.ctro.2024.100887.
Prognostic Significance of Recurrence and Timing of Recurrence on Survival Among Patients with Early-Stage Hepatocellular Carcinoma in U.S. Clinical Practice.
Maithel S, Wang R, Harton J, Yopp A, Shah S, Rocha F
Ann Surg Oncol. 2024; 32(2):1054-1062.
PMID: 39623184
DOI: 10.1245/s10434-024-16476-2.